Company Filing History:
6 out of 1,929 
3 out of 1,209 
3 out of 2,963 
Years Active: 1999-2019
Title: Suzanne Ostrand-Rosenberg: Pioneering Cancer Immunotherapy
Introduction
Suzanne Ostrand-Rosenberg is a prominent inventor based in Columbia, MD (US). She has made significant contributions to the field of cancer immunotherapy, holding a total of 9 patents. Her innovative work focuses on reversing immune suppression in cancer patients, providing new avenues for therapeutic interventions.
Latest Patents
One of her latest patents is titled "Soluble CD80 as a therapeutic to reverse immune suppression in cancer patients." This invention presents a therapeutic cancer treatment utilizing a soluble CD80 fusion protein that binds to PDL1. By inhibiting PDL1-PD1 interactions, this approach aims to overcome PDL1-induced immune suppression and restore T cell activation. This groundbreaking work has the potential to significantly enhance the effectiveness of cancer treatments.
Career Highlights
Throughout her career, Suzanne has worked with esteemed institutions such as the University System of Maryland and Dana-Farber Cancer Institute Inc. Her research has been instrumental in advancing our understanding of immune responses in cancer therapy.
Collaborations
Some of her notable collaborators include Laurie H. Glimcher and Gordon James Freeman. Their combined expertise has contributed to the development of innovative solutions in cancer treatment.
Conclusion
Suzanne Ostrand-Rosenberg's contributions to cancer immunotherapy through her patents and collaborations highlight her as a leading figure in the field. Her work continues to inspire advancements in therapeutic strategies for cancer patients.